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%mmaryy-Scatchard anaIysis of the binding to opioid receptors of [3H~thylket~yci~~jne Q3H]EKC) 
and 13~to~hine at quiIib~um yielded biphasic plots and computer fitting of the data resulted in a 
minima1 model of two inde~ndent saturabit binding sites. The Kn v&es for the high- and Iow-affinity 
sites were 0.58 and 38 nM for [3H]EKC, and 0. I3 and 22 nM for j3H)etorphine. The corresponding density 
of binding sites was 157 and 418 fmol/mg protein for [3H]EKC, and 220 and 289 fmoI/mg protein for 
rH]etorphine. The Kn values caIcuIated from the association and dissociation rate constants corresponded 
to those observed at equilibrium. In the course of equilibrium binding, various opioids competed with 
[)H]EKC and [3H]etorphine preferentially at the high-affinity opioid receptor sites. No difference between 
the competition patterns of putative p and K hgands was observed. 
The kinetics of association and dissociation of rH]EKC and [3H]ttorphine revealed that the apparently 
homogeneous high-affinity binding site observed at quihbrium consisted of two components character- 
ized by their fast and slow qui~ib~~ times, respectively. While none of the p and K opiates investigated 
altered the rate of dissociation of [“HJEKC or [‘H]etorphine, in the presence of soditmi ions the rapidIy 
dissociating binding component of f3H]etorphine became refractory to inhibition by p but not K agonists. 
The resuhs underline the advantages of evaluating both quilbrium binding and the kinetics of 
Iigand-receptor interactions. 
Key words: multiple opioid receptors, equilibrium binding, binding kinetics, ethylketocyclazocine, 
etorphine, rat brain, brain membranes. 
In the research on multiple opioid receptors, the 
characterization of opioid alkaloids as hgands for the 
postulated p and K types of receptor has been ham- 
pered by the considerable cross-reactivity of these 
compounds, particularly pronounced in membranes 
of the rat brain (Kosterlitz and Paterson, 1980; 
Pfeiffer and Hem, 1981; Magnan, Paterson, Tavani 
and Kosterlitz, 1982). Although lately some novel 
alkaloids have been described which exhibited dis- 
tinct K activity in bioassay systems (Romer, Hill and 
Maurer, 1982; von Voigtlander, Lahti and Ludens, 
1983; Lahti, Mickelson, McCall and von Voigtlander, 
1985), ethylketocyclazocine (EKC) has widely been 
used as a K agonist in studies of ligand binding to 
opioid receptors in membranes of the rat brain (Hiller 
and Simon, 1980; Pasternak, 1980; Snyder and Good- 
man, 1980; Chang, Hazum and Cuatrecasas, 1980). 
However, the shortcomings of this opiate and of the 
brain of the rat as the ligand and tissue of choice to’ 
characterize the K opioid receptor have recently been 
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emphasized (Goldstein and James, 19&1). Indeed, 
apparently due to the lack of selectivity, the findings 
of early binding studies have failed to substantiate the 
existence of separate receptors for narcotic drugs of 
the K type in the brain of the rat. Subsequently, 
partial support for discrete K sites in rat brain was 
obtained from simultaneous computer analysis of 
the binding of labelled p and K opiates (Pfeiffer and 
Herr, 1982) and from competitive ligand displace- 
ment in brain membranes from the rat (Chang, 
Hazum and Cuatrecasas, 1981; Wolozin, Nishimura 
and Pastemak, 1982) and mouse (Garzon, Sanchez- 
Blazquez and Lee, 1984). 
Recently, it has been possible to differentiate be- 
tween putative h and K opiates on the basis of their 
responses to sodium in displacing 13HJEKC and 
[3H~to~hine in membranes from rat and pigeon 
brain (Med~hra~ky, Dahlstrom, Woods, Fischel 
and Mitsos, 1984). The biphasic nature of the bind- 
ing of opiate alkaloids in membranes from the brain 
of the rat has also been described and the strong 
influence of methodology on the outcome oi the 
kinetic analysis of opioid receptor binding has been 
demonstrated (Fischel and Medzihradsky, 1981). As 
a follow-up to these studies, the present work has 
investigated the interaction between [3H]EKC and 
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opioid receptors in membranes from the brain of the 
rat under conditions of (a) equilibrium binding, (b) 
association and dissociation, and (c) competitive 
inhibition by different opioid alkaloids. The aim was 
to probe the resolution of the binding of K opioid 
receptors in membranes of the rat brain, obtainable 
by the kinetic approach with EKC as the prototype 
ligand. For comparative purposes, the relevant prop- 
erties of tritiated etorphine, an opiate with broad 




[‘H]Ethylketocyclazocine (15 Ci/mmol) and [3H]- 
etorphine (39 Ci/mmol) were purchased from New 
England Nuclear Co., Boston, Massachusetts, U.S.A. 
and Amersham Corp., Arlington Heights, Illinois, 
U.S.A., respectively. The radiochemical purity of 
these compounds was 98%, as ascertained by thin- 
layer chromatography on silica gel G plates (Eastman 
Kodak Corp., Rochester, New York, U.S.A.) in 
two different solvent systems recommended by the 
manufacturers. 
The uniabelled opiates were obtained through the 
Drug Abuse Basic Research Center at The University 
of Michigan. The enantiomers (1 R, 5R, 9R, 2’R)-5,9- 
dimethyl -2” - tetrahydrofurfuryl- 6,7 - benzomorphan 
(UMl071-R) and the all-S isomer of UM1071-R 
(UMl071-S) are N-furyl-substituted benzomorphans 
with widely diverging K agonist activity (Medzihrad- 
sky et al., 1984; Woods, Smith, Medzihradsky 
and Swain, 1979), and were used in this study as 
the pharmacologically active and inactive isomer, 
respectively. 5,9-Diethyl-2-(3-furylmethyl)-2’-hy- 
droxy-6,7benzomorphan (MR2266) is a N-furyl- 
substituted benzomorphan antagonist that was 
classified as a K opiate (Woods et al., 1979), but in 
different studies had varying potency toward p and K 
agonists (Lord, Waterfield, Hughes and Kosterlitz, 
1977; Barchfeld, Maassen and Medzihradsky, 1982). 
Biochemical agents were purchased from Sigma 
Chemical Co., St Louis, Missouri, U.S.A. Other 
compounds were of reagent grade, and were obtained 
from commercial distributors of chemicals. 
Isolation and pretreatment of membranes 
Parts of this procedure have been published pre- 
viously (Fischel and Medzihradsky, 1981). Male, 
Sprague-Dawley rats weighing 200g were decapi- 
tated and the cerebra pooled in 100 vol of ice-cold 
50 mM Tris-HCl buffer, pH 7.4. After disrupting the 
tissue using a Polytron homogenizer, the resulting 
homogenate was centrifuged at 20,000 g for 15 min at 
4°C. The pellet was resuspended in the same volume 
of the Tris buffer using a Dounce homogenizer. 
Aliquots of this suspension, sufficient for one experi- 
ment, were frozen at -70C. The concentration of 
protein in these samples was approx. 0.6 mgjml and 
opiate receptor binding was shown to be stable under 
such conditions for at least 6 months. 
Upon thawing, the membranes were suspended in 
a Dounce homogenizer and used as such, or were 
subjected to an initial incubation. In the latter case. 
the membranes were centrifuged at 20,OOOg for 
15 min, the pellet was resuspended in 50 mM 
Tris-HCl buffer, pH 7.4 at 37°C and the suspension 
then incubated at 37°C for 40 min. After a repeated 
centrifugation at 20,OOOg for I5 min at 4”C, the pellet 
was resuspended in the appropriate buffer medium 
for the assay of receptor binding. Unless otherwise 
specified, the buffer was 50mM Tris-HCl, adjusted 
to pH 7.4 at the assay temperature. 
Analysis of receptor binding at equilibrium 
To 8 ml polypropylene tubes in an ice-water bath, 
were added 400~1 membrane suspension (approx. 
200 pg protein), 50 ~1 distilled water or 50 ~1 1,575 M 
NaCl (final concentration in assay 150 mM) and 
50 ~1 distilled water or solution of unlabelled drug. 
Unless specified otherwise, the assay mixture was 
incubated in a shaking water bath for 15 min at 25°C. 
After the addition of 25 ~1 aliquots of the radio- 
labelled ligand, the assay tubes were incubated to 
reach equilibrium in ligand binding and then either 
placed in an ice-water bath for 10 min or filtered 
directly. Prior to use, the Whatman GF/C filters 
employed were soaked in distilled water and washed 
on the filter assembly three times with 5 ml aliquots 
of distilled water saturated with amyl alcohol 
(Medzihradsky, 1976). The tube and the filtered 
material were rinsed with three 4ml aliquots of 
ice-cold 50 mM Tris-HCl, pH 7.4. The filters were 
transferred into scintillation vials, 1 ml of absolute 
ethanol and 10 ml of a dioxane-xylene-napththalene 
scintillation mixture were added and the samples 
subjected to liquid scintillation counting. Average 
counting efficiency was 36% as determined by the use 
of ‘HzO. 
The actual concentration of tritiated drug present 
in the assay medium was determined by counting 
aliquots of the corresponding stock solution prepared 
for that particular experiment. Specific, i.e. receptor- 
related, interaction of the radiolabelled ligand was 
determined either with a stereospecific “binding win- 
dow” (Fischel and Medzihradsky, 1981) established 
for [3H]EKC with the active and inactive isomers 
UMl071-R/UMl071-S and for [-‘H]etorphine with 
levorphanol/dextrorphan, or was defined as the 
difference in binding obtained in the absence and 
presence of IO p M unlabelled ligand. 
Analysis of receptor binding kinetics 
These experiments were performed as described 
above with the following exceptions. To determine 
the rates of ligand-receptor association, the assay was 
terminated at various times before and after binding 
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Table I. Equations for computer modeling of nonlinear binding data 
Model Equation 
One binding site + one linear component “I V-1 h = - + k,[L] 
K,, + IL1 
Two binding sites fj_!!!E!_+ n*lU 
K,,+ILl K,,+ILl 
Two binding sites + one linear component 
&P-l a[Y h = - + - + k,.(L] 
Ko,+ILl Ko,+]Ll 
One co-operative binding site 
Multiple dissociation rates 
Multiple association rates 
b = amount of ligand bound at concentration, IL], or time, I; $ = amount of ligand 
bound at equilibrium; n, = number of binding sites for site i; K, = equilibrium 
dissociation constant for site i; k, = linear binding constant; nH = Hill coefficient; 
k, = association rate constant; k_, = dissociation rate constant; A, = fractional 
contribution of site, to the total number of sites; j = number of diRerent types of 
sites bound at equilibrium. 
equilibrium. The kinetics of ligand-receptor dis- 
sociation were assessed by the method of “infinite 
dilution” (DeMeyts, Bianco and Roth, 1976), i.e. the 
reassociation of the radiolabelled ligand with the 
receptor was prevented by dilution in the presence of 
excess unlabelled ligand. Membrane suspensions 
were incubated with a tritiated opiate to equilibrium, 
centrifuged at 20,000 g at 4°C for 15 min, and rapidly 
suspended in 2 ml of ice-cold 50 mM Tris-HCl, 
pH 7.4 at 25°C. Ligand dissociation was initiated by 
the addition of 50~1 aliquots of this suspension to 
tubes containing 5 ml of prewarmed (25°C) 50 mM 
Tris-HCI buffer, pH 7.4, with or without 1 PM un- 
labelled ligand. Samples were filtered at the time of 
this addition (defined as 100% binding) and at vari- 
ous times thereafter. 
Determination of protein 
The method of Lowry et al. was applied (Lowry, 
Rosebrough, Farr and Randall, 1951). Standards of 
crystalized, lyophilized bovine serum albumin were 
prepared using the same buffer medium present in the 
biological samples being tested, unless it was demon- 
strated experimentally that the components of the 
medium did not interfere with the protein assay 
(Peterson, 1979). 
Methods of computer analysis and statistical evalu- 
ation 
The results from both equilibrium binding and 
kinetic experiments were evaluated using NONLIN, 
a weighted nonlinear least-squares regression analysis 
program (Metzler, 1969). The data were weighted 
according to the inverse of the observed experimental 
values (Boxenbaum, Riegelman and Elasoff, 1981) 
and were fitted to one or more of the appropriate 
equations listed in Table 1. Initial estimates for 
binding parameters were obtained from the respective 
double reciprocal plots (Neal, 1972), or by using 
CSTRIP, a computerized feathering technique for 
obtaining estimates from multiphasic exponential 
curves (Sedman and Wagner, 1976). The appropriate- 
ness of a binding mode1 was assessed by the distribu- 
tion of the weighted residuals about the theoretical 
curve and by the extent to which the sum of the 
weighted squared deviations was minimized. The 
significance of differences between the binding 
models was evaluated statistically using the F-ratio 
test (Table 2). Statistical differences between the 
calculated binding constants or between the means of 
various experiments were evaluted using a two-tailed 
Student’s t-test (Boxenbaum et al., 1981). 
RESULTS 
Equilibrium binding 
Specific binding of [‘H]EKC, determined within 
the linear range of membrane protein dependence, 
reached equilibrium after 40 min at 25”C, both in the 
absence and presence of sodium. In agreement with 
the results of previous studies (Simon, Hiller and 
Edelman, 1973; Tolkovsky, 1982), steady-state in the 
receptor binding of (3H]etorphine was obtained after 
20min incubation at 25°C. Scatchard analysis of 
specific binding of [3H]EKC revealed (Fig. 1A) that 
the presence of 150 mM NaCl decreased the number 
of high-affinity binding sites by 50% with no changes 
in the corresponding K, (Table 2). Prior incubation 
of the membranes increased the number of high- 
affinity binding sites 1.6-fold without altering the K, 
either in the presence or absence of Na+. Thus, the 
pretreatment did not change the numerical value of 
the sodium ratio in [)H]EKC binding (binding in the 
absence of Na+/binding in the presence of Na+). 
Neither initial incubation of membrane nor Na+ 
altered the interaction between [)H]EKC and the 
low-affinity specific binding sites. Computer analysis 
demonstrated that the model, consisting of two non- 
interacting saturable binding sites (Table l), provided 
the best fit for the data obtained (Table 2). Although 
no statistically-significant difference between the two- 
saturable-site model and the one-cooperative-site 
mode1 was obtained in the presence of NaCl, dis- 
sociation experiments, using the method of infinite 
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Table 2. Equilibrium binding parameters for [‘H]EKC assuming different models of ligand-receptor interactions 
Binding site models 
Binding parameters I saturable and I linear 2 saturable 2 saturable and I linear I co-operative 
- Preincubarion. - NaCl 
Kn, (nM) 
n, (fmolimg protein) 
Kn,, (nM) 
nr (fmohmg protein) 




- Preincubation. f NaCl 
Ko, (nM) 
tt, (fmol/mg protein) 
Kn, (nM) 
n2 (fmol/mg protein) 




+ Preincubarion, - NaCl 
Ko, (nM) 
n, (fmol/mg protein) 
Ko, (nM) 
nr (fmolimg protein) 
k, (fmol/mg protein. nM) 
:WSD 
Significance 
+ Preincubation, + NaCl 
Ko, (nM) 
n, (fmol/mg protein) 
Kn, (nM) 
nr (fmohmg protein) 





228 k I8 
- 
- 




2.5 + 0.4 
224 & 20 
- 
- 




0.62 f 0.07 
330 + I4 
- 
- 












0.58 i 0.06 0.56 I 0.08 
157 * IO 154* I5 
38 f 7 31+20 
418 f I9 357 * 159 






0.41 f 0.20 
60* I7 
l3&3 





0.30 * 0.20 
46 _t 20 
9.1 k 3.6 
276 i: 36 




0.40 * 0.06 
252 5 22 
22 ? 8 





0.40 f 0.13 
ll4*25 
II +3 





0.37 i 0.08 
237 I 35 
I3 * II 
237 + 69 




0.39 * 0. I3 
112525 
II t3 
309 f 27 




6.1 t 1.3 




0.53 _t 0.05 
5.65 
P<0.001 
6.1 f 0.05 












0.58 + 0.04 
18.5 
0.001 <P <0.005 
3.5 * 0.3 




0.64 * 0.03 
9.75 
NS 
*Not significant (P >O. IO). 
The values listed are the computer-estimated means and standard deviations for the best fit of the data to the binding models listed below 
and defined in Table I. The experiments and the statistical treatment of the data are described in the legend to Figure I and in Methods. 
All of the experiments were carried out at 25C in the absence and presence of I50 mM NaCl using untreated and initially incubated 
membranes, respectively. The concentration of [‘H]EKC in the assay ranged up to 100 nM. Significance, indicated by results of F-ratio 
tests. relates to the statistical difference of the data relative to that for the model with two saturable sites. The computer-estimated mean 
values and the corresponding standard deviations are shown. The estimationfor each experimental condition was based on I8 data points 
obtained in 2 separate experiments. SWSD = sum of the weighted squared deviations (criterion of the variance ratio, or F-test). 
dilution, revealed the lack of cooperative interactions 
(data not shown). Specific binding, determined by 
excess of unlabelled ligand, was completely 
stereospecific as shown by the use of UMIO’Il-R, a 
potent K agonist and its virtually inactive enantiomer 
UM1071-S as displacing agents (Fig. 1, inset). 
As described above for the receptor binding of 
[‘HIEKC, Scatchard analysis and computer fitting to 
binding modets resolved specific binding of 
[‘Hletorphine into two components with no evidence 
of negative cooperativity (Fig. 1 B). The respective Ko 
values (nM) in the absence and presence of Na+ were 
0.13 f 0.02 and 22 + 7 for [‘HIEKC, and 0.06 * 0.03 
and 5.3 + 2.2 for [‘Hletorphine. The corresponding 
values for n, and n2 (fmol/mg protein) were 220 + 1 I 
and 289 f 24, while with Na+ they were 114 + 22 and 
177 + 24. As was the case for [‘HIEKC, prior incu- 
bation of the membrane did not alter the extent of the 
sodium ratio for [3H]etorphine (data not shown). The 
slight, statistically-insignificant, discrepancies in the 
numerical values of the binding parameters for the 
high-affinity site listed in Tables 2 and 4 are due to 
different modes of fitting the data. 
Competitive interactions assessed at equilibrium 
Various concentrations of the radiolabelled ligand 
were incubated in the absence and presence of a 
constant concentration of a given unlabelled opiate 
(Table 4). The latter concentration was selected to 
inhibit the specific binding of 0.5 nM radiolabelled 
ligand by 30-50%. Initially, the results were evalu- 
ated by computer analysis for binding to a two- 
saturable-site model. Since no statistically-significant 
inhibition of the low-affinity binding site was ob- 
served, the data for all experiments within a given set 
of conditions (e.g. inhibition of radiolabelled ligand 
binding in either the absence and presence of NaCl) 
were fitted simultaneously, assuming no changes in 
the binding parameters of the low-affinity binding 
site. This approach has increased the statistical pre- 
cision in evaluating the kinetic constants of the 
high-affinity binding sites. The uniabelled opiates 
increased the apparent Kus 2- to 7-fold for [3H]EKC 
and [3H]etorphine without decreasing the number of 
corresponding binding sites. This behaviour was in- 
dicative of a non-cooperative, competitive interaction 
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Fig. 1. Scatchard analysis of specific binding of [‘HIethyl- 
ketocyclazocine and rH]etorphine. The opioid receptor- 
related binding of 0.1-50 nM radiolabelled EKC (A) and 
etorphine (B) in the absence (0, A) and presence (0, A) 
of 15OmM NaCl was determined after incubation for 
40 min at 25°C as described. in Methods. Cerebral mem- 
branes were used either directly (A, A) or subjected to an 
initial incubation for 40 min at 37°C (0, 0). Specific inter- 
action was defined either as the difference between ligand 
binding in the absence and presence of 10pM labelled 
ligand, or as stereospecific binding determined by the use of 
UMl071-S (0) and UMl071-R (W) in the case of [)H]EKC 
and dextrorphan and levorphanol in the case of [3H]- 
etorphine. The optimal concentrations of these enantiomers 
to displace the radiolabelled ligands were determined as 
illustrated for [‘H]EKC binding (inset). The concentration 
of [‘H]EKC and [‘HJetorphine (not shown) in these experi- 
ments reflected the range used in the Scatchard analyses. 
The specific and sterospecific binding of fH]EKC and 
[3H]etorphine were shown to be equivalent under all of the 
assay conditions used. The averages of data obtained in 2 
experiments. each run with duplicate samples are shown. 
(A) (8) 
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Fig. 2. Kinetics of specific binding and dissociation of 
[31iJethylketoeyelazocine and [3H]etorphine. These experi- 
ments were carried out at 25°C in the absence (0) or 
presence (0) of 15OmM NaCl with cerebral membranes 
which had been subjected to prior incubation. To investigate 
the association kinetics, specific binding of 0.5 nM of [‘HI- 
EKC (A) or [3HJetorphine (C) were determined as described 
in Methods. The ordinate represents the natural logarithm 
of the specific binding at equilibrium divided by the 
difference between that quantity and the specific binding at 
the times indicated (Bennett, 1978). In the experiments on 
ligand dissociation, the membrane suspension was incu- 
bated with 0.5nM of [3H]EKC (B) or [3H]etorphine (D). 
Reassociation was prevented by the addition of unlabelled 
ligand to yield a final concentration of 10 PM as described 
in Methods. The percentage of specifically bound [3H]EKC 
or [)H]etorphine at various times after the dilution is 
plotted. The averages of two experiments with duplicate 
samples are shown. The corresponding results of the 
individual experiments differed by less than 5%. 
between both p and K opiates at the high-affinity 
binding sites for the radiolabelled ligands (Table 4). 
Kinetics of ligand binding and dissociation 
The rates of association and dissociation of 
[‘HJEKC and [3H]etorphine revealed two phases 
(Fig. 2 and Table 3) of the high-affinity ligand- 
receptor interaction, which appeared homogeneous 
under conditions of equilibrium binding (Fig. 1 and 
Table 2). Both in the absence and presence of Na+ 
the two phases were characterized by fast and slow 
equilibration, respectively. The Kn values calculated 
from the respective rate constants were similar to 
those obtained for the high-affinity binding sites from 
the data of the equilibrium binding experiments 
(Tables 2 and 3, and text). 
Competitive ligand dissociation 
In these experiments, the interaction between 
different opiates and the two’dissociating phases of 
[3H]EKC (not shown) and [‘Hletorphine binding 
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Table 3. Rate constants for specific binding of [“H]EKC and [‘Hletorphine 
Component I Component 2 
NaCl k, k-1 K Dcnlc kz k-2 Ko& 
(oM) (min-‘Me’) (min-‘) (oM) (min-‘Mm’) (min-‘) (nM) 
['H]EKC 
0 8.1 x IO' 9.7 x 10-J 0.12 5.4 x 108 1.0 x lo-' 0.19 
I50 I x I08 2.5 x IO-' 0.25 4x 108 5.0 x IO..’ 1.0 
[JH]Emrphine 
0 2.8 x IO’ 2.2 x 10-J 0.079 2.9 x IO8 5.8 x IO-’ 0.20 
I50 5.4 x IO’ I.4 x 10-1 0.026 5.5 x IO” 4.1 x 10-Z 0.075 
The listed data are the computer-estimated values for the experiments described in Fig. 2. K,,,, 
is defined as k-,/k, or k-,/k, 
(Fig. 3) was investigated. The binding of 0.5 nM 
[3H]EKC or [‘Hletorphine was allowed to reach equi- 
librium in the absence and presence of an unlabelled 
opiate. After initiating dissociation of radiolabelled 







Fig 3. Dissociation of [‘Hletorphine from opioid receptors 
in the presence of competing ligands. Untreated cerebral 
membranes were incubated with 0.5 nM [‘Hletorphine to 
equilibrium at 25°C alone (0) or with enough unlabelled 
opiates to inhibit the specific binding by approx. 20% in the 
absence or presence of I50 mM NaCl. Unlabelled opiates 
included the antagonists (ANT) nahrexone (A) and 
MR2266 (m), the p agonists (AG) morphine (0) and 
levorphanol (V) and the K agonists EKC (0) and 
UMl071-R (0). Two to four drugs were tested simul- 
taneously in single experiments. Ligand dissociation was 
initiated by the addition of IO FM unlabelled etorphine. The 
results of one to three determinations for each drug were 
evaluated by nonlinear least squares regression analysis as 
described in Methods. T’he statistical significance of differ- 
ences between the percentage contributions of the slow 
dissociative component in the presence and absence of 
unlabelled drugs was determined by the two-tailed Student’s 
r-test with 9 to 28 dJ The P-values listed in the Figure 
indicate the significance of the data compared to the control. 
NS = not significant. 
fast and slow phases and their relative contribution to 
total radiolabelled ligand binding were determined. 
None of the unlabelled opiates significantly altered 
the rate of dissociation of [3H]EKC or [-‘H]etorphine 
under any of the experimental conditions. These 
findings indicated that the competing ligands bound 
to the fast and slow dissociating sites in a non- 
cooperative manner, in agreement with the corre- 
sponding results of equilibrium binding (Table 4). In 
the absence of NaCl, competing opiates altered the 
relative contribution of the slowly- and rapidly- 
dissociating components to total specific binding of 
[‘H]EKC and [3H]etorphine: significantly greater in- 
hibition of the slow component occurred. However, 
the extent of inhibition by putative p and K ligands 
was indistinguishable (Fig. 3). On the other hand, in 
the presence of Na+, a differential effect of fl and K 
opiates on the dissociation of [3H]etorphine (but not 
of [‘H]EKC) became apparent. Whereas p agonists 
reduced the contribution of the slow component to 
specific binding at equilibrium from 53 to 35%, K 
agonists had little or no effect. Putative antagonists 
of either type of opioid receptor produced no 
significant changes in the distribution of the two 
dissociative phases (Fig. 3). 
DISCUSSION 
Analysis of nonlinear receptor binding. 
Biphasic specific binding of opiates, as shown in 
this study for [3H]EKC and [-‘H]etorphine, has fre- 
quently been ascribed to the presence of two different 
populations of receptor sites. However, other biolog- 
ical (DeMeyts, Roth, Neville, Gavin and Lesniak, 
1973) or methodological (Fischel and Medzihradsky, 
1981) factors can be responsible for such findings. 
Negatively cooperative ligand-receptor interactions 
were shown to be responsible for the biphasic binding 
of insulin to a variety of tissues (JDeMeyts et al., 
1976). This conclusion was based primarily on the 
ability of unlabelled insulin to accelerate the dis- 
sociation rate of previously bound [iZSI]insulin 
(DeMeyts et al., 1973). By this criterion, as well as by 
the “goodness of fit” of the data to allosteric or 
multiple site models by a computer-modelling pro- 
cedure, the opioid receptor binding of [‘H]EKC and 
[‘Hletorphine in the present work was shown to be 
best described by two populations of non-interacting 
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Table 4. Interaction between c and K opiates and specific binding of [‘HJEKC and [‘HJctorpbine at quilibrium 
-NaCI f NaCl 
Apparent Ko Apparent K, 
Competing lipnd (nM) (fmol/mi protein) (nM) (fmol/mp” protein) 
I’H]EKC: High-afinity binding sire 
None 0.61 kO.08 I63 f I2 0.58 k 0.23 75* I8 
Morphine 0.87 kO.13 139 f 13 1.12 co.33 104_t21 
EKC t.05 f 0.14 159 + I4 1.37 k 0.37 III &22 
Low -afinily binding site 
None 39 + 8 405*20 l6k3 312 + I7 
[3H]Etorphinc: High -urnity binding sire 
None 0.11 kO.01 204*7 0.065 f 0.021 t22+12 
Morphine 0.35 f 0.03 218 *9 0.39 * 0.09 172 f I7 
Levorphanol 0.65 f 0.07 200*12 ND* ND 
Naltrexone 0.51 +0.05 204210 0.25 f 0.06 160+16 
EKC 0.37 * 0.03 l84*8 0.33 f. 0.08 154+16 
UM 1071 0.65 f 0.07 200*12 ND ND 
MR 2266 0.86 f 0.08 251 f I2 0.38 f 0.09 127 + 17 
Low-u@ti~y binding sire 
None 20+3 319 f I2 14*s 235 2 21 
*Not determined. 
Untrcatcd cerebral mcmbrana were incubated with a constant amount of unlabelled ligand and varying 
concentrations (O.l-50nM) of [‘H]EKC or [‘mtorphinc to equilibrium at 25°C. The concentration of 
unlab&d opiate was sufficient to inhibit the spa&c binding of 0.5 nM radiolabelkd ligand by 30%. Specific 
binding was determined in the absence and prwcncc of IO p M of the respective unlakllcd ligand. Samples 
were placed on iti for 10 min immediately prior to ftration. The data obtained in the absence sod presence 
of l50mM NaCl were pooled separately, and subjected to simultaneous nonlinear kast squares regression 
analysis as deacrihed in the text. The significance of the data was determined using the Student’s r-test. Shown 
arc the computcrcstimatcd means and standard deviations for 27 to 58 points obtained in %6 experiments 
([‘HJEKC) and for 41 to 80 data points obtainod in 5-7 experiments ([‘H]etorphinc). 
saturable binding sites with different affinities, rather 
than by an occupancy-dependent isomerization of 
a single site (Tolkovsky, 1982). In contrast to the 
receptor model with distinctive non-interacting bind- 
ing sites for the opioid alkaloids investigated in this 
work, the binding of morphine and leucine en- 
kephalin in membranes from the rat brain was best 
described by two allosterically-coupled populations 
of sites (Rothman and Westfall, 1982a, 1982b). Ac- 
cording to that model, the binding of morphine (and 
etorphine) masks, and thus modulates, the binding 
sites for the opioid peptide. A similar model, de- 
picting allosteric interaction between K and b opioid 
ligands binding to different sites on a common recep 
tor molecule (endorphin receptor), has also been 
proposed (Smith and Lee, 1983). It is of interest to 
point out that these allosteric models of the opioid 
receptor are based on the binding patterns of pairs of 
chemically-dissimilar ligands, i.e. an alkaloid and 
peptide. In contrast, in the previous study (Fischel 
and Medzihradsky, 1981) and present work, the 
receptor binding of opioid alkaloids has been de- 
scribed, whereby the data favored a two-site rather 
than an allosteric model. A recent kinetic study of the 
binding of opioid agonists and antagonists in mem- 
branes from the rat brain has shown that opioid 
alkaloids, in contrast to opioid peptides, interact with 
multiple receptor sites (Scheibe, Bennett, Spain, Roth 
and Coscia, 1984). 
The kinetics of receptor binding carried out in 
this study confirmed the relevance of the proposed 
model and provided further resolution. The kinetic 
data revealed that high-affinity ligand binding con- 
sisted of two components, equilibrating at different 
rates, not distinguishable by equilibrium binding 
methods. Using [3HXD-AlaZ-D-LeuS)enkephalin, a 
slowly dissociating ligand-opioid receptor complex 
has previously been described in synaptic membranes 
from bovine brain (Pryhuber, Roth and Coscia, 
1982). This observation has led to the postulation of 
a multistep mechanism for opioid agonists, whereby 
the rapidly reversible ligand-receptor complex ini- 
tially formed is converted into a slowly-dissociating 
high-affinity conformation (Scheibe et al., 1984). The 
comparison of these findings with the present data is 
hampered by the use of opioid agonist peptides in one 
and alkaloids in the other. Nonetheless, in apparent 
contrast to the multistep binding model for agonists, 
multiple dissociation components for the antagonist 
[3H]naltrexone have also been described (Fischel 
and Medzihradsky, 1981). It should also be noted 
that similar Kr, values for the receptor binding of 
t3H’Jnaltrexone (Fischel and Medzihradsky, 1981), 
[%JEKC and [3H]etorphine (see Results) were ob- 
tained at equilibrium and kinetically. However, in 
neither study an occupancy-dependent shift in ligand 
binding affinity and pattern of dissociation has been 
specifically tested for. 
Sign$cance of high and low ajinity binding sites 
In early studies on opioid receptor binding, the 
marked depression of the high-affinity component for 
[3H]dihydromorphine in the presence of sodium ions 
led to the suggestion that antagonists and agonists 
bind to the high and low-affinity sites, respectively 
(Pasternak and Snyder, 1975). However, sub- 
sequently pure opioid agonists were shown to dis- 
place high-affinity binding sites (Lord et al., 1977). 
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Indeed. as shown in this study, both agonists and 
antagonists competed preferentially for the high- 
affinity binding sites (Table 4). In this respect the 
present data, obtained with membranes from rat 
brain, provide no support for the recently proposed 
receptor model of separate recognition sites for 
opioid agonists and antagonists (Portoghese and 
Takemori, 1983). 
In membranes from transformed neural cells, un- 
labelled IC and 6 opiates competed preferentially with 
the low-affinity component of the [‘H]EKC binding 
isotherm (West, McLawhon, Dawson and Miller, 
1981). Correspondingly, it was proposed that the 
high-affinity binding site, termed p,, is common to all 
opiates and. is responsible for analgesia, whereas 
ligand interaction at the lower affinity receptor sites 
mediates the specific effects of the different types of 
opiates (Pasternak, 1980; Wolozin et al., 1982). On 
the other hand, the results in this paper show that 
in membrane preparations from rat cerebra, a partial 
resolution in the dissociation of p and K opiates was 
achieved at ligand concentrations which favored the 
binding to the high-affinity sites of [3H]EKC and 
[3H]etorphine. 
Discrimination between the receptor binding of 
[3H]EKC and [3H]erorphine 
The classification of p and IC opiates in membranes 
from the rat brain has recently been described on the 
basis of their differential sensitivity toward sodium 
ions in binding to receptor (Medzihradsky et al., 
1984). A possible molecular correlate for this resolu- 
tion was revealed by the kinetics of ligand binding 
determined in the present study. The high affinity 
binding of [‘H]EKC and [‘Hletorphine consisted of 
two components. In the presence of sodium, the 
rapidly-dissociating phase of OH]etorphine binding 
became refractory to inhibition by p but not K 
agonists, thus revealing a degree of discrimination 
between these types of opiates at the high-affinity 
binding sites. Since the unlabelled opiate alkaloids 
altered the relative contribution of the rapidly and 
slowly equilibrating components to total ligand bind- 
ing without affecting the respective dissociation rates, 
their interaction with receptor was competitive rather 
than cooperative in nature. In view of the different 
[“HIEKC and [‘Hletorphine was inhibited by both p 
and K opiates, it would have been tempting to assume 
that it represents the nI sites, and the rapidly equi- 
librating component the K binding sites. However. in 
such a case one of the dissociative components of 
[3H]EKC should have been insensitive to inhibition 
by p agonists. To what extent conformational 
changes between receptor forms of different affinity 
(Scheibe et al., 1984) represent a general phenomenon 
for the binding of opioid ligands remains to be 
assessed. A higher degree of resolution of the K 
receptor in membranes from the rat brain can be 
expected from the use of either radiolabelled opiates 
with increased specificity (e.g. von Voigtlander et al., 
1983; Lahti et al., 1985) or unlabelled irreversible 
ligands specifically alkylating discrete populations of 
opioid receptor sites (James and Goldstein, 1984; 
Clark and Medzihradsky, 1986). An alternative and 
comprehensive approach is the study of opioid recep- 
tor heterogeneity in systems where receptor-effector 
coupling represents an additional molecular diversity 
which contributes to the biological differentiation of 
the action of opiates (Barchfeld et al., 1982; Barchfeld 
and Medzihradsky, 1984; Clark and Medzihradsky, 
1986). In this respect, the heterogeneity of opioid 
receptors can be expressed by the nature of the 
effector system, and the mechanism and efficacy of 
coupling. However, the results of this study show that 
even under conditions of unfavorable ligand and 
tissue specificity, the analysis of ligand association 
and dissocation kinetics, in addition to the assess- 
ment of equilibrium binding, represents a valuable 
approach in characterizing the interaction between 
ligands and opioid receptors. 
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